Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.

Nagata M, Noman AA, Suzuki K, Kurita H, Ohnishi M, Ohyama T, Kitamura N, Kobayashi T, Uematsu K, Takahashi K, Kodama N, Kawase T, Hoshina H, Ikeda N, Shingaki S, Takagi R.

BMC Cancer. 2013 Sep 5;13:410. doi: 10.1186/1471-2407-13-410.

2.

Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma.

Kurokawa A, Nagata M, Kitamura N, Noman AA, Ohnishi M, Ohyama T, Kobayashi T, Shingaki S, Takagi R; Oral, Maxillofacial Pathology, and Surgery Group..

Cancer. 2008 Mar 15;112(6):1272-81. doi: 10.1002/cncr.23295.

3.
4.

Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.

Hirano C, Nagata M, Noman AA, Kitamura N, Ohnishi M, Ohyama T, Kobayashi T, Suzuki K, Yoshizawa M, Izumi N, Fujita H, Takagi R.

Int J Cancer. 2009 Jun 15;124(12):2911-6. doi: 10.1002/ijc.24297.

5.

Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, Karavidas K, Jay A, Sandison A, Thomas GJ, Kalavrezos N, Hopper C.

Head Neck Oncol. 2010 Apr 20;2:9. doi: 10.1186/1758-3284-2-9.

6.

Downregulation of CD9 protein expression is associated with aggressive behavior of oral squamous cell carcinoma.

Buim ME, Lourenço SV, Carvalho KC, Cardim R, Pereira C, Carvalho AL, Fregnani JH, Soares FA.

Oral Oncol. 2010 Mar;46(3):166-71. doi: 10.1016/j.oraloncology.2009.11.009. Epub 2010 Jan 8.

PMID:
20060356
7.

Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.

Kim MJ, Lim KY, Kim JW, Nam IW, Lee JH, Myoung H.

Cancer Lett. 2005 Jun 28;224(2):253-61.

PMID:
15914276
8.

Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma.

Parris TZ, Aziz L, Kovács A, Hajizadeh S, Nemes S, Semaan M, Chen CY, Karlsson P, Helou K.

BMC Cancer. 2014 May 7;14:324. doi: 10.1186/1471-2407-14-324.

9.

Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.

Montebugnoli L, Gissi DB, Badiali G, Marchetti C, Cervellati F, Farnedi A, Foschini MP.

J Oral Maxillofac Surg. 2011 Oct;69(10):2579-84. doi: 10.1016/j.joms.2010.10.041. Epub 2011 Feb 3.

PMID:
21292374
10.

High expression of Naa10p associates with lymph node metastasis and predicts favorable prognosis of oral squamous cell carcinoma.

Zeng Y, Zheng J, Zhao J, Jia PR, Yang Y, Yang GJ, Ma JF, Gu YQ, Xu J.

Tumour Biol. 2016 May;37(5):6719-28. doi: 10.1007/s13277-015-4563-z. Epub 2015 Dec 9.

PMID:
26662107
11.

Loss of motility-related protein 1 (MRP1/CD9) and integrin alpha3 expression in endometrial cancers.

Miyamoto S, Maruyama A, Okugawa K, Akazawa K, Baba H, Maehara Y, Mekada E.

Cancer. 2001 Aug 1;92(3):542-8.

PMID:
11505398
12.

KiSS-1 expression in oral squamous cell carcinoma and its prognostic significance.

Shin WJ, Cho YA, Kang KR, Kim JH, Hong SD, Lee JI, Hong SP, Yoon HJ.

APMIS. 2016 Apr;124(4):291-8. doi: 10.1111/apm.12507. Epub 2016 Jan 25.

PMID:
26809635
13.

Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival.

Linhares MM, Affonso RJ Jr, Viana Lde S, Silva SR, Denadai MV, de Toledo SR, Matos D.

PLoS One. 2015 Dec 16;10(12):e0144333. doi: 10.1371/journal.pone.0144333. eCollection 2015.

14.

KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.

Zhang BH, Liu W, Li L, Lu JG, Sun YN, Jin DJ, Xu XY.

Asian Pac J Cancer Prev. 2013;14(6):3521-6.

15.
16.

Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells.

Dmello C, Sawant S, Alam H, Gangadaran P, Tiwari R, Dongre H, Rana N, Barve S, Costea DE, Chaukar D, Kane S, Pant H, Vaidya M.

Int J Biochem Cell Biol. 2016 Jan;70:161-72. doi: 10.1016/j.biocel.2015.11.015. Epub 2015 Nov 29.

PMID:
26646105
17.

Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.

Kono M, Watanabe M, Abukawa H, Hasegawa O, Satomi T, Chikazu D.

J Oral Maxillofac Surg. 2013 Oct;71(10):1694-702. doi: 10.1016/j.joms.2013.04.015. Epub 2013 Jul 1.

PMID:
23809761
18.

Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma.

Lin YT, Chuang HC, Chen CH, Armas GL, Chen HK, Fang FM, Huang CC, Chien CY.

BMC Cancer. 2012 May 28;12:194. doi: 10.1186/1471-2407-12-194.

19.

Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.

Cheng SJ, Liu YC, Cheng SL, Lee JJ, Chen HM, Chang HH, Kok SH, Kuo MY, Chiang CP.

J Oral Pathol Med. 2013 Aug;42(7):565-9. doi: 10.1111/jop.12050. Epub 2013 Feb 25.

PMID:
23438080
20.

Axl is a prognostic marker in oral squamous cell carcinoma.

Lee CH, Yen CY, Liu SY, Chen CK, Chiang CF, Shiah SG, Chen PH, Shieh YS.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S500-8. doi: 10.1245/s10434-011-1985-8. Epub 2011 Aug 13.

PMID:
21842265

Supplemental Content

Support Center